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Abstract
Background: In addition to mediating the integration process, HIV-1 integrase (IN) has also been
implicated in different steps during viral life cycle including reverse transcription and viral DNA nuclear
import. Although the karyophilic property of HIV-1 IN has been well demonstrated using a variety of
experimental approaches, the definition of domain(s) and/or motif(s) within the protein that mediate viral
DNA nuclear import and its mechanism are still disputed and controversial. In this study, we performed
mutagenic analyses to investigate the contribution of different regions in the C-terminal domain of HIV-1
IN to protein nuclear localization as well as their effects on virus infection.
Results: Our analysis showed that replacing lysine residues in two highly conserved tri-lysine regions,
which are located within previously described Region C (235WKGPAKLLWKGEGAVV) and sequence Q
(211KELQKQITK) in the C-terminal domain of HIV-1 IN, impaired protein nuclear accumulation, while
mutations for RK263,4 had no significant effect. Analysis of their effects on viral infection in a VSV-G
pseudotyped RT/IN trans-complemented HIV-1 single cycle replication system revealed that all three C-
terminal mutant viruses (KK215,9AA, KK240,4AE and RK263,4AA) exhibited more severe defect of
induction of β-Gal positive cells and luciferase activity than an IN class 1 mutant D64E in HeLa-CD4-
CCR5-β-Gal cells, and in dividing as well as non-dividing C8166 T cells, suggesting that some viral defects
are occurring prior to viral integration. Furthermore, by analyzing viral DNA synthesis and the nucleus-
associated viral DNA level, the results clearly showed that, although all three C-terminal mutants inhibited
viral reverse transcription to different extents, the KK240,4AE mutant exhibited most profound effect on
this step, whereas KK215,9AA significantly impaired viral DNA nuclear import. In addition, our analysis
could not detect viral DNA integration in each C-terminal mutant infection, even though they displayed
various low levels of nucleus-associated viral DNA, suggesting that these C-terminal mutants also impaired
viral DNA integration ability.
Conclusion: All of these results indicate that, in addition to being involved in HIV-1 reverse transcription
and integration, the C-terminal tri-lysine regions of IN also contribute to efficient viral DNA nuclear
import during the early stage of HIV-1 replication.
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The integrase (IN) of human immunodeficiency virus
type 1 (HIV-1) is encoded by the pol gene and catalyzes
integration of viral cDNA into host chromosome, an
essential step in HIV-1 replication. In addition to mediat-
ing the integration process, HIV-1 IN also participates in
different steps during viral life cycle, including reverse
transcription and viral DNA nuclear import [1-6]. During
early phase of the HIV-1 replication cycle, after virus entry
into target cells, another pol gene product, reverse tran-
scriptase (RT), copies viral genomic RNA into double-
stranded cDNA which exists within a nucleoprotein pre-
integration complex (PIC). The PIC also contains viral
proteins including RT, IN, nucleocapsid (NC, p9), Vpr
and matrix (MA, p17) and this large nucleoprotein com-
plex is capable of actively translocating into the cell
nucleus, including that of non-dividing cells (reviewed in
reference [7]). This feature is particularly important for
the establishment of HIV-1 replication and pathogenesis
in exposed hosts, since the infection of postmitotic cells
including tissue macrophages, mucosal dendritic cells as
well as non-dividing T cells may be essential not only for
viral transmission and dissemination, but also for the
establishment of persistent viral reservoirs.
HIV-1 IN is composed of three functional domains, an N-
terminal domain, a central catalytic core domain and a C-
terminal domain, all of which are required for a complete
integration reaction. The N-terminal domain harbors an
HHCC-type zinc binding domain and is implicated in the
multimerization of the protein and contributes to the spe-
cific recognition of DNA ends [8-10]. The core domain of
IN contains the highly conserved DDE motif which is
important for catalytic activity of the protein [11,12]. The
C-terminal domain was shown to possess nonspecific
DNA binding properties [13,14]. Some mutations within
this region cause a drastic loss of virus infectivity without
affecting the enzymatic activity of IN in vitro [2,13-16].
There are three conserved sequences in the C-terminus of
IN that are essential for HIV-1 replication. Regions C
(235WKGPAKLLWKGEGAVV) and N (259VVPRRKAK) are
conserved in all known retroviruses and the
211KELQKQITK motif falls within the so-called glutamine-
rich based region (sequence Q) of lentiviruses [17]. Alter-
ation of each of the three sequences such as Q214L/
Q216L, K215A/K219A, W235E, K236A/K240A, K244A/
E246A, RRE263-5AAH resulted in loss of viral replication
[15-18]. However, the mechanism(s) underlying the loss
of viral infectivity remains controversial.
A number of studies have demonstrated the karyophilic
properties of IN implicating that this protein may play an
important role for PIC nuclear import [3,19-23]. How-
ever, the definition of nuclear localization signals (NLSs)
in IN as well as their contribution to HIV-1 PIC nuclear
import still remain to be determined. Previous report has
suggested an atypical bipartite NLS (186KRK and
211KELQKQITK) by showing that IN mutants K186Q and
Q214/216L in these regions lost the protein nuclear local-
ization and their inability to bind to karyopherin α in vitro
[3]. However, in attempt to analyze the effect of these
mutants during HIV-1 replication, other studies did not
reveal the importance of these IN mutants (K186Q and
Q214/216L) for viral nuclear import; rather they appear
to be required for reverse transcription, integration or
undefined post-nuclear entry steps [16,18,23]. Also,
another IN amino acid sequence IIGQVRDQAEHLK
(aa161–173), was initially identified as an atypical NLS,
which is required for viral DNA nuclear import [19]. How-
ever, reassessments of this putative NLS function failed to
confirm this conclusion [24,25]. Some reports have also
acknowledged that IN localization could result from pas-
sive diffusion of the protein and its DNA binding property
[26,27], but DNA binding alone does not fully explain a
rapid, ATP- and temperature-dependent nuclear import of
IN [20]. It has recently been reported that the nuclear
translocation of HIV-1 IN can be attributed to its interac-
tion with a cellular component, human lens epithelium-
derived growth factor/transcription coactivator p75
(LEDGF/p75) and LEDGF/p75 was also shown to be a
component of HIV PIC [28,29]. However, whether this
IN/LEDGF/p75 interaction plays an important role for
HIV-1 nuclear import still remains to be elucidated, since
HIV-1 infection and replication in LEDGF/p75-deficient
cells was equivalent to that in control cells, regardless
whether cells were dividing or growth arrested [29]. Thus,
even though extensive studies have been dedicated in this
specific research field, the contribution of HIV-1 IN to
viral PIC nuclear import remains to be defined.
In this study, we have performed substitution mutational
analysis to investigate the contribution of different C-ter-
minal regions of IN to protein nuclear localization and
their effects on HIV-1 replication. Our results showed that
mutations of lysine residues in two tri-lysine regions,
which are located within previously described Region C
and sequence Q [17] in the C-terminal domain of HIV-1
IN, impaired protein nuclear localization, while muta-
tions of arginines at amino acid position of 263 and 264
in the distal part of the C-terminal domain of IN had no
significant effect. Moreover, we assessed the effect of these
IN mutants during HIV-1 single cycle infection mediated
by VSV-G pseudotyped RT/IN trans-complemented
viruses. Results showed that, while all three C-terminal
mutant viruses differentially affected HIV-1 reverse tran-
scription, the KK240,4AE mutant exhibited most pro-
found inhibition on this step, whereas KK215,9AA
significantly impaired viral DNA nuclear import.Page 2 of 15
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The C-terminal domain of HIV-1 integrase (IN) is required 
for the nuclear localization of IN-YFP fusion protein
In this study, we first investigated the intracellular locali-
zation of HIV-1 IN and delineated the region(s) of IN con-
tributing to its karyophilic property. A HIV-1 IN-YFP
fusion protein expressor (CMV-IN-YFP) was generated by
fusing a full-length HIV-1 IN cDNA (amplified from HIV-
1 HxBru molecular clone [30]) to the 5' end of YFP cDNA
in a CMV-IN-YFP expressor, as described in Materials and
Methods. Transfection of CMV-IN-YFP expressor in 293T
cells resulted in the expression of a 57 kDa IN-YFP fusion
protein (Fig. 1B, lane 2; Fig. 2B, lane 1), whereas expres-
sion of YFP alone resulted in a 27 kDa protein (Fig. 2B,
lane 5). Given that HeLa cells have well-defined morphol-
ogy and are suitable for observation of intracellular pro-
tein distribution, we tested the intracellular localization of
YFP and IN-YFP by transfecting CMV-IN-YFP or CMV-YFP
expressor in HeLa cells. After 48 hours of transfection,
cells were fixed and subjected to indirect immunofluores-
cence assay using primary rabbit anti-GFP antibody fol-
lowed by secondary FITC-conjugated anti-rabbit
antibodies. Results showed that, in contrast to a diffused
intracellular localization pattern of YFP (data not shown),
the IN-YFP fusion protein was predominantly localized in
the nucleus (Fig 1C, a1), confirming the karyophilic fea-
ture of HIV-1 IN.
To delineate the karyophilic determinant in HIV-1 IN, two
truncated IN-YFP expressors CMV-IN50–288-YFP and CMV-
IN1–212-YFP were generated. In CMV-IN50–288-YFP, the N-
terminal HH-CC domain of IN (aa 1–49) was deleted and
in CMV-IN1–212-YFP, the C-terminal domain (aa 213–
288) was removed (Fig. 1A). Transfection of each trun-
cated IN-YFP fusion protein expressor in 293T cells
resulted in the expression of IN50–288-YFP and IN1–212-YFP
at approximately 52 kDa and 48 kDa molecular mass
respectively (Fig. 1B, lanes 3 and 4). We next investigated
the intracellular localization of truncated IN-YFP fusion
proteins in HeLa cells by using indirect immunofluores-
cence assay, as described above. Results showed that the
IN50–288-YFP was predominantly localized in the nucleus
with a similar pattern as the wild-type IN-YFP fusion pro-
tein (Fig. 1C, compare b1 to a1). However, IN1–212-YFP
fusion protein was excluded from the nucleus, with an
accumulation of the mutant protein in the cytoplasm (Fig
1C, c1). These results were also further confirmed by using
rabbit anti-IN antibody immunofluorescence assay (data
not shown). Taken together, our data show that the C-ter-
minal domain of HIV-1 IN is required for its nuclear
accumulation.
Two tri-lysine regions in the C-terminal domain of IN are 
involved in the protein nuclear localization
The C-terminal domain of HIV-1 IN contains several
regions that are highly conserved in different HIV-1
strains, including Q, C and N regions [17]. Interestingly,
in regions Q and C, sequences of 211KELQKQITK and
236KGPAKLLWK possess high similarity in terms of num-
bers and position of lysine residues and therefore, we term
them proximal tri-lysine region and distal tri-lysine
region, respectively (Fig. 2A). All of these lysine residues
are highly conserved in most HIV-1 strains [31]. To test
whether these basic lysine residues could constitute for a
possible nuclear localization signal for IN nuclear locali-
zation, we specifically introduced substitution mutations
for two lysines in each tri-lysine region and generated
INKK215,9AA-YFP and INKK240,4AE-YFP expressors (Fig. 2A).
In the conserved N region, there is a stretch of four basic
residues among five amino acids (aa) 262RRKAK. To char-
acterize whether this basic aa region may contributes to IN
nuclear localization, we replaced an arginine and a lysine
at positions of 263 and 264 by alanines in this region and
generated a mutant (INRK263,4AA-YFP). The protein expres-
sion of different IN-YFP mutants in 293T cells showed
that, like the wild type IN-YFP, each IN-YFP mutant fusion
protein was detected at similar molecular mass (57 kDa)
in SDS-PAGE (Fig 2B, lanes 1 to 4), while YFP alone was
detected at position of 27 kDa (lane 5). Then, the intrac-
ellular localization of each IN mutant was investigated in
HeLa cells by using similar methods, as described above.
Results showed that, while the wild type IN-YFP and
INRK263,4AA-YFP still predominantly localized to the
nucleus (Fig. 2C, a1 and d1), both INKK215,9AA-YFP and
INKK240,4AE-YFP fusion proteins were shown to distribute
throughout the cytoplasm and nucleus, but with much
less intensity in the nucleus (Fig 2C, a1 and b1). These
data suggest that these lysine residues in each tri-lysine
regions are required for efficient HIV-1 IN nuclear
localization.
Production of VSV-G pseudotyped HIV-1 IN mutant viruses 
and their effects on HIV-1 infection
Given that two di-lysine mutants located in the C-termi-
nal domain of IN are involved in HIV-1 IN nuclear local-
ization, we next evaluated whether these IN mutants
would affect the efficiency of HIV-1 infection. To specifi-
cally analyze the effect of IN mutants in early steps of viral
infection, we modified a previously described HIV-1 sin-
gle-cycle replication system [32] and constructed a RT/IN/
Env gene-deleted HIV-1 provirus NLluc∆Bgl∆RI, in which
the nef gene was replaced by a firefly luciferase gene [33].
Co-expression of NLluc∆Bgl∆RI provirus with Vpr-RT-IN
expressor and a vesicular stomatitis virus G (VSV-G) glyc-
oprotein expressor will produce viral particles that can
undergo a single-round of replication, since RT, IN and
Env defects of provirus will be complemented in trans byPage 3 of 15
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incorporation [32]. This single cycle replication system
allows us to introduce different mutations into IN gene
sequence without differentially affecting viral morpho-
genesis and the activity of the central DNA Flap. After dif-
ferent IN mutations KK215,9AA, KK240,4AE and
RR263,4AA were introduced into Vpr-RT-IN expressor, we
produced VSV-G pseudotyped HIV-1 IN mutant virus
stocks in 293T cells. In order to specifically investigate the
effect of IN mutants on early steps during HIV-1 infection
prior to integration, an IN class I mutant D64E was also
included as control. After each viral stock was produced
(as indicated in Fig. 3A), similar amounts of each virus
stock (quantified by virion-associated RT activity) were
lysed and virus composition and trans-incorporation of
RT and IN of each virus stock were analyzed by Western
blot analysis with anti-IN and anti-HIV antibodies, as
described in Materials and Methods. Results showed that
Subcellular localization of the wild-type and truncated HIV integrase fused with YFPFigure 1
Subcellular localization of the wild-type and truncated HIV integrase fused with YFP. A) Schematic structure of 
HIV-1 integrase-YFP fusion proteins. Full-length (1–288aa) HIV-1 integrase, the N-terminus-truncated mutant (51–228aa) or 
the C-terminus-truncated mutant (1–212aa) was fused in frame at the N-terminus of YFP protein. The cDNA encoding for 
each IN-YFP fusion protein was inserted in a SVCMV expression plasmid. B) Expression of different IN-YFP fusion proteins in 
293T cells. 293T cells were transfected with each IN-YFP expressor and at 48 hours of transfection, cells were lysed, immuno-
precipitated with anti-HIV serum and resolved by electrophoresis through a 12.5% SDS-PAGE followed by Western blot with 
rabbit anti-GFP antibody. The molecular weight markers are indicated at the left side of the gel. C) Intracellular localization of 
different IN-YFP fusion proteins. HeLa cells were transfected with each HIV-1 IN-YFP fusion protein expressor and at 48 
hours of transfection, cells were fixed and subjected to indirect immunofluorescence using rabbit anti-GFP and then incubated 
with FITC-conjugated anti-rabbit antibodies. The localization of each fusion protein was viewed by Fluorescence microscopy 
with a 50× oil immersion objective. Upper panel is fluorescence images and bottom panel is DAPI nucleus staining.Page 4 of 15
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els of Gagp24, IN and RT, as compared to the wild-type
virus (Fig. 3A), indicating that trans-incorporation of RT
and IN as well as HIV-1 Gag processing were not differen-
tially affected by the introduced IN mutations.
To test the infectivity of different IN mutant viruses in
HeLa-CD4-CCR5-LTR-β-Gal cells, we first compared the
infectivity of VSV-G pseudotyped wild type virus and the
D64E mutant virus. At 48 hours post-infection with equiv-
alent amount of each virus stock (at 1 cpm RT activity/
cell), the number of β-Gal positive cells was evaluated by
MAGI assay, as described previously [34]. Results showed
that the number of infected cells (β-Gal positive cells) for
D64E mutant reached approximately 14% of the wild
type level (data not shown). This result is consistent with
a previous report showing that, in HeLa MAGI assay, the
infectivity level of class I IN integration-defect mutant was
approximately 20 to 22% of wild type level [15]. It indi-
cates that, even though the IN mutant D64E virus is defec-
tive for integrating viral DNA into host genome, tat
expression from nucleus-associated and unintegrated viral
DNAs can activate HIV-1 LTR-driven β-Gal expression in
HeLa-CD4-CCR5-LTR-β-Gal cells. Indeed, several studies
have already shown that HIV infection leads to selective
transcription of tat and nef genes before integration
Effect of different IN C-terminal substitution mutants on IN-YFP intracellular localizationFigure 2
Effect of different IN C-terminal substitution mutants on IN-YFP intracellular localization. A) Diagram of HIV-1 
IN domain structure and introduced mutations at the C-terminal domain of the protein. The position of lysines in two tri-
lysine regions and introduced mutations are shown at the bottom of sequence. B) The expression of the wild-type and mutant 
IN-YFP fusion proteins were detected in transfected 293T cells by using immunoprecipitation with anti-HIV serum and West-
ern blot with rabbit anti-GFP antibody, as described in figure 1. The molecular weight markers are indicated at the left side of 
the gel. C) Intracellular localization of different HIV-1 IN mutant-YFP fusion proteins in HeLa cells were analyzed by fluores-
cence microscopy with a 50× oil immersion objective. The nucleus of HeLa cells was simultaneously visualized by DAPI staining 
(lower panel).Page 5 of 15
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infection system provides an ideal method for us to
evaluate the effect of different IN mutants on early steps of
viral infection prior to integration. We next infected HeLa-
CD4-CCR5-LTR-β-Gal cells with different VSV-G pseudo-
typed IN mutant viruses at higher infection dose of 10
cpm RT activity/cell and numbers of β-Gal positive cells
were evaluated by MAGI assay after 48 hours of infection.
Interestingly, results showed that the IN mutant D64E
virus infection induced the highest level of β-Gal positive
cells, whereas infection with viruses containing IN
mutants KK215,9AA, KK240,4AE or RK263,4AA yielded
much lower levels of β-Gal positive cells, which only
reached approximately 11%, 5% or 26% of the level of
D64E virus infection (Fig. 3B). Based on these results, we
reasoned that these IN C-terminal mutants blocked infec-
tion mostly by affecting earlier steps of HIV-1 life cycle,
such as reverse transcription and/or viral DNA nuclear
import steps, which are different from the action of D64E
mutant on viral DNA integration.
Effect of IN mutants on viral infection in dividing and non-
dividing C8166 T cells
To further test whether these C-terminal mutants could
induce similar phenotypes in CD4+ T cells, we infected
dividing and non-dividing (aphidicolin-treated) C8166
CD4+ T cells with equal amounts of VSV-G pseudotyped
IN mutant viruses (at 5 cpm of RT activity/cell). Since all
IN mutant viruses contain a luciferase (luc) gene in place
of the nef gene, viral infection can be monitored by using
a sensitive luc assay which could efficiently detect viral
gene expression from integrated and unintegrated viral
DNA [33]. After 48 hours of infection, equal amounts of
cells were lysed in 50 µl of luc lysis buffer and then, 10 µl
of cell lysates was used for measurement of luc activity, as
described in Materials and Methods. Results showed that
the D64E mutant infection in dividing C8166 T cells
induced 14.3 × 104 RLU of luc activity (Fig. 4A), which
was approximately 1000-fold lower than that in the wild
type virus infection (data not shown). This level of luc
activity detected in D64E mutant infection is mostly due
Production of different single-cycle replicating viruses and their infection in HeLa-CD4-CCR5-β-Gal cellsFigure 3
Production of different single-cycle replicating viruses and their infection in HeLa-CD4-CCR5-β-Gal cells. A). 
To evaluate the trans-incorporation of RT and IN in VSV-G pseudotyped viral particles, viruses released from 293T cells trans-
fected with NLluc∆Bgl∆RI provirus alone (lane 6) or cotransfected with different Vpr-RT-IN expressors and a VSV-G 
expressor (lane 1 to 5) were lysed, immunoprecipitated with anti-HIV serum. Then, immunoprecipitates were run in 12% SDS-
PAGE and analyzed by Western blot with rabbit anti-IN antibody (middle panel) or anti-RT and anti-p24 monoclonal antibody 
(upper and lower panel). B) The infectivity of trans-complemented viruses produced in 293 T cells was evaluated by MAGI 
assay. HeLa-CD4-CCR5-LTR-β-Gal cells were infected with equal amounts (at 10 cpm/cell) of different IN mutant viruses and 
after 48 hours of infection, numbers of β-Gal positive cells (infected cell) were monitored by X-gal staining. Error bars repre-
sent variation between duplicate samples and the data is representative of results obtained in three independent experiments.Page 6 of 15
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agreement with the finding by MAGI assay described in
figure 3, the Luc activity detected in KK215,9AA,
KK240,4AE and RK263,4AA mutant samples were approx-
imately 13%, 5% and 36% of level of D64E mutant infec-
tion (Fig. 4A). In parallel, infection of different IN
mutants in non-dividing C8166 T cells was also evaluated
and similar results were observed (Fig. 4B).
To test whether these IN mutants had similar effects dur-
ing HIV-1 envelope-mediated single cycle infection, we
produced virus stocks by co-transfecting 293T cells with a
HIV-1 envelope-competent NLluc∆RI provirus with each
Vpr-RT-IN mutant expressor, as described in Materials and
Methods. Then, dividing CD4+ C8166 cells were infected
with each virus stock (at 10 cpm RT activity/cells). At 48
hours post-infection, cells were collected and measured
for luc activity. Results from figure 4C showed that, simi-
lar to results obtained from VSV-G pseudotyped virus
infection (Fig. 4A), the Luc activity detected in cells
infected by HIV-1 envelope competent KK215,9AA,
KK240,4AE and RK263,4AA mutant viruses were approxi-
mately 13.5%, 6% and 29% of level of D64E mutant
infection (Fig. 4C). All of these results confirm the data
from HeLa-CD4-CCR5-LTR-β-Gal infection (Fig. 3) by
using either VSV-G- and HIV-1 envelope-mediated infec-
tions and suggest again that the significantly attenuated
infection of KK215,9AA, KK240,4AE and RK263,4AA
mutant viruses may be due to their defect(s) at reverse
transcription and/or viral DNA nuclear import steps.
Effects of IN mutants on reverse transcription, viral DNA 
nuclear import and integration
All results so far suggest that these C-terminal mutants
might significantly affect early steps during HIV-1 replica-
tion. To directly assess the effect of these IN C-terminal
mutants on each early step during viral infection, we ana-
lyzed the viral DNA synthesis, their nuclear translocation
and integration following each IN mutant infection in
dividing C8166 cells. Levels of HIV-1 late reverse tran-
scription products were analyzed by semi-quantitative
PCR after 12 hours of infection with HIV-1 specific 5'-LTR-
U3/3'-Gag primers and Southern blot, as previously
described [32,37]. Also, intensity of amplified HIV-1
Effect of IN mutants on viral infection in dividing and nondividing C8166 T cellsFigure 4
Effect of IN mutants on viral infection in dividing and nondividing C8166 T cells. To test the effect of different IN 
mutants on HIV-1 infection in CD4+ T cells, dividing (panel A) and non-dividing (aphidicolin-treated, panel B) C8166 T cells 
were infected with equal amount of VSV-G pseudotyped IN mutant viruses (at 5 cpm/cell). For evaluation of the effect of differ-
ent IN mutants on HIV-1 envelope-mediated infection in CD4+ T cells, dividing C8166 T cells were infected with equal amount 
of HIV-1 envelope competent IN mutant viruses (at 10 cpm/cell) (panel C). After 48 hours of infection, HIV-1 DNA-mediated 
luciferase induction was monitored by luciferase assay. Briefly, the same amount (106 cells) of cells was lysed in 50 ul of luci-
ferase lysis buffer and then, 10 µl of cell lysate was subjected to the luciferase assay. Error bars represent variation between 
duplicate samples and the data is representative of results obtained in three independent experiments.Page 7 of 15
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densitometric scanning of bands in Southern blot autora-
diograms (Fig. 5A). Results showed that total viral DNA
synthesis in both KK215,9AA and RK263,4AA infection
reached approximately 61% and 46% of that of the wild
type (wt) virus infection (Fig. 5A and 5B). Strikingly, in
KK240,4AA sample, detection of viral DNA synthesis was
drastically reduced, which only reached 21% of viral DNA
level in WT sample (Fig. 5A and 5B). These results indicate
that all three C-terminal mutants negatively affected viral
reverse transcription during viral infection and
KK240,4AA mutant exhibited most profound effect.
Meanwhile, the nucleus- and cytoplasm-associated viral
DNA levels were analyzed at 24 hours post-infection in
C8166 T cells. The infected cells were first gently lysed and
separated into nuclear and cytoplasmic fractions by using
a previously described fractionation technique [37]. Then,
levels of HIV-1 late reverse transcription products in each
fraction were analyzed by semi-quantitative PCR, as
Effects of different IN mutants on HIV-1 reverse transcription and DNA nuclear importFigure 5
Effects of different IN mutants on HIV-1 reverse transcription and DNA nuclear import. Dividing C8166 T cells 
were infected with equal amounts of different HIV-1 IN mutant viruses. A) At 12 hours post-infection, 1 × 106 cells were lysed 
and the total viral DNA was detected by PCR using HIV-1 LTR-Gag primers and Southern blot. B) Levels of HIV-1 late reverse 
transcription products detected in panel A were quantified by laser densitometry and viral DNA level of the wt virus was arbi-
trarily set as 100%. Means and standard deviations from two independent experiments are presented. C) At 24 hours post-
infection, 2 × 106 cells were fractionated into cytoplasmic and nuclear fractions as described in Materials and Methods. The 
amount of viral DNA in cytoplasmic and nuclear fractions were analyzed by PCR using HIV-1 LTR-Gag primers and Southern 
blot (upper panel, N. nuclear fraction; C. cytoplasmic fraction). Purity and DNA content of each subcellular fraction were mon-
itored by PCR detection of human globin DNA and visualized by specific Southern blot (lower panel). D). The percentage of 
nucleus-associated viral DNA relative to the total amount of viral DNA for each mutant was also quantified by laser densitom-
etry. Means and standard deviations from two independent experiments are shown.Page 8 of 15
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terminal mutants on HIV-1 DNA nuclear import. In the
wt, D64E and RK263,4AA virus-infected samples, there
were respectively 70%, 72% and 68% of viral DNA associ-
ated with nuclear fractions (Fig. 5C (upper panel, lanes 1
and 2; 3 and 4; 9 and 10) and 5D). For KK240,4AE
mutant, approximately 51% of viral DNA was nucleus-
associated (Fig. 5C (upper panel, lane 7 and 8) and 5D).
Remarkably, in KK215,9AA infected sample, viral cDNA
was found predominantly in the cytoplasm and only
approximately 21% of viral DNA was associated with the
nuclear fraction (Fig. 5C (upper panel, lane 5 and 6) and
5D). Meanwhile, the integrity of fractionation procedure
was validated by detection of β-globin DNA, which was
found solely in the nucleus and levels of this nucleus-asso-
ciated cellular DNA were similar in each nuclear sample
(Fig. 5C, lower panel).
Even though the C-terminal mutants were shown to sig-
nificantly affect HIV-1 reverse transcription and/or
nuclear import, the various low levels of nucleus-associ-
ated viral DNA during the early stage of replication (Fig.
5C) may still be accessible for viral DNA integration. To
address this question, 1 × 106 dividing C8166 T cells were
infected with equivalent amounts of each single cycle rep-
licating virus stock (5 cpm/cell), as indicated in figure 6
and after 24 hours of infection, the virus integration level
was checked by using a previously described sensitive Alu-
PCR technique [32], Results revealed that, while the wt
virus resulted in an efficient viral DNA integration (Fig. 6,
upper panel; lanes 1 and 2), there was no viral DNA inte-
gration detected in D64E mutant (lanes 3 to 4) and in all
three C-terminal mutant infection samples (lanes 5 to
10), although similar levels of cellular β-globin gene were
detected in each sample (Fig. 6, middle panel). These
results suggest that, in addition to affecting HIV-1 reverse
transcription and nuclear import, all three C-terminal IN
mutants tested in this study also negatively affected viral
DNA integration. Overall, all of these results indicate that
all three IN C-terminal mutants are belonged to class II
mutants, which affected different early steps during HIV-1
replication. Among these mutants, the KK240,4AE
showed the most profound inhibition on reverse tran-
scription and the KK215,9AA, and to a lesser extent,
KK240,4AE, impaired viral DNA nuclear translocation
during early HIV-1 infection in C8166 T cells.
Discussion
In this study, we performed mutagenic studies to analyze
different regions in the C-terminal domain of HIV-1 IN
that contribute to protein nuclear localization as well as
their effects on virus infection. First, our analyses showed
that specific lysine mutations introduced in two highly
conserved tri-lysine regions in the C-terminal domain of
HIV-1 IN impaired protein nuclear accumulation. Second,
infection experiments revealed that all three C-terminal
mutant viruses (KK215,9AA, KK240,4AE and RK263,4AA)
exhibited more severe defect of induction of β-Gal posi-
tive cells and luc activity, as compared to an IN class 1
mutant D64E virus, in CD4+ HeLa-β-Gal cells, dividing
and non-dividing C8166 T cells. It suggests that all three
C-terminal mutant virus infections may have defects at
steps prior to integration. Further analysis of total viral
DNA synthesis, viral DNA nuclear import and integration
indicates that all three C-terminal mutants displayed a
class II mutant profile. Even though all of them reduced
viral reverse transcription levels, the mutant KK240,4AE
showed the most profound inhibitory effect. In addition,
the mutant KK215,9AA, and to a lesser extent,
KK240,4AE, impaired viral DNA nuclear translocation.
These IN mutant-induced defects do not appear to result
from various effects of mutants on Gag-Pol processing
and maturation given that RT and IN were complemented
in trans in this HIV-1 single-cycle infection system. Rather,
the effect of different IN mutants on reverse transcription
and viral DNA nuclear import is likely originated from a
role of mutants within the maturing PIC complexes.
Previous work by Gallay et al., have proposed an atypical
bipartite NLS (186KRK and 211KELQKQITK) in HIV-1 IN
by finding that IN mutants K186Q and Q214/216L lost
their karyophilic feature and their ability to bind to kary-
opherin α in vitro [3]. Even though these results were con-
firmed by Petit and colleagues by studying the
intracellular localization of HIV-1 Flag-IN [18], other
studies, using GFP-IN fusion protein, did not reveal the
importance of K186Q and Q214/216L mutations for HIV-
1 IN nuclear localization [16,23,27]. Therefore, the defini-
tion of region(s) in HIV-1 IN contributing to the protein
nuclear localization is still controversial. In this study, we
investigated the intracellular localization of several IN-
YFP fusion proteins including the C-terminal-deletion
mutant IN1–212-YFP, substitution mutants INKK215,9AA-YFP
and INKK240,4AE-YFP and found that all of these IN fusion
mutants impaired protein nuclear accumulation. It sug-
gests that two C-terminal tri-lysine regions
211KELQKQITK and 236KGPAKLLWK contribute to IN
nuclear localization. Interestingly, the study by Maertens
et al also showed that the fusion of HIV-1 IN C-terminal
fragment alone with GFP rendered fusion protein to be
exclusively in the nucleus, speculating that the C-terminal
domain may have a role in HIV-1 nuclear import [28].
However, at this moment, we still could not exclude the
possibility that the IN nuclear accumulation could be
facilitated by the DNA binding ability of IN protein, as
suggested by Devroe et al [27]. It has to be noted that two
studies have previously observed the nuclear localization
of GFP-IN fusion proteins although the C-terminal
domain of IN was deleted from the fusion protein
[23,28]. It has also been shown that both N-terminal zincPage 9 of 15
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are involved in its interaction with a cellular protein,
human lens epithelium-derived growth factor/transcrip-
tion coactivator p75 (LEDGF/p75) and this IN/LEDGF/
p75 interaction is required for GFP-IN nuclear localiza-
tion [28]. However, our deletion analysis by using IN-YFP
fusion protein failed to reveal the importance of both N-
terminal and core domains for IN nuclear localization
(Fig. 1). One explanation for this discrepancy could be
different orientations of fusion proteins used in our study
(IN-YFP) and other studies (GFP-IN). It is possible that
different forms of fusion proteins may differentially affect
the ability of IN to interact with LEDGF/p75 and conse-
quently affect their ability for nuclear targeting. Therefore,
it would be interesting to test whether INKK215,9AA-YFP and
INKK240,4AE-YFP could loss their ability to interact with
LEDGF/p75. These studies are underway.
An important question that needs to be addressed is the
impact of nuclear localization-defective IN mutants on
HIV-1 replication. Given that most IN mutants character-
ized so far are classified as class II mutants that cause plei-
otropic damage including defects in viral morphogenesis,
reverse transcription and integration [16,38], we used a
previously described VSV-G pseudotyped HIV-1 RT/IN
trans-complement single-cycle replication system [32,39]
to minimize differential effects of IN mutants on virus
maturation. Also, in our infection experiments, a specific
integration-defective class I mutant D64E virus was intro-
duced in order to monitor the viral gene expression from
unintegrated HIV-1 DNA species that are already translo-
cated into nucleus during virus infection. It is known that
certain levels of selected viral gene expression (tat and nef)
from unintegrated viral DNA species are detected during
this Class I mutant infection [2,35,36]. Interestingly, our
Effect of IN mutants on HIV-1 proviral DNA integrationFigure 6
Effect of IN mutants on HIV-1 proviral DNA integration. Dividing C8166 T cells were infected with equal amounts of 
different HIV-1 IN mutant viruses. At 24 hours post-infection, 1 × 106 cells were lysed and serial-diluted cell lysates were ana-
lyzed by two-step Alu-PCR and Southern blot for specific detection of integrated proviral DNA from infected cells (Upper 
panel). The DNA content of each lysis sample was also monitored by PCR detection of human β-globin DNA and visualized by 
specific Southern blot (middle panel). The serial-diluted ACH-2 cell lysates were analyzed for integrated viral DNA and as 
quantitative control (lower panel). The results are representative for two independent experiments.Page 10 of 15
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defects were found for all three IN C-terminal mutant
viruses KK215,9AA, KK240,4AE and RK263,4AA than
D64E mutant virus in Hela-CD4-CCR5-β-Gal cells, divid-
ing and non-dividing C8166 T cells (Fig. 3 and 4). These
results suggest that these C-terminal IN mutants may
affect early steps such as reverse transcription and/or
nuclear import and consequently result in a reduced level
of viral DNA in the nucleus, which is accessible for tat and
nef expression, To understand the mechanism(s) underly-
ing replication defects of each C-terminal mutant, levels
of total reverse transcription were analyzed during early
viral infection. Consistent with a previous study [6], infec-
tion with D64E mutant virus did not affect reverse tran-
scription as compared to wt virus infection. However, all
three C-terminal mutants display various levels of
impaired HIV-1 reverse transcription (Fig. 5A and 5B).
The mutant KK240,4AE showed strongest inhibition of
reverse transcription (21% compared to the wt level
(100%)), while mutants KK215,9AA and RK263,4AA
reached to 61% and 46% (Fig. 5A and 5B). These data
indicate that all of these IN mutants, especially
KK240,4AA, negatively affect reverse transcription at early
viral infection. Consistently, recent studies have shown
that the C-terminal domain of IN contributes to efficient
reverse transcription and this domain of IN was able to
bind to heterodimeric RT [6,40,41]. It is possible that
these C-terminal mutants, especially for KK240,4AE, may
disrupt the interaction between IN and RT and result in
decreased viral cDNA synthesis.
Subsequently, we examined levels of nucleus- and cyto-
plasm-associated viral DNA during early virus infection.
Results clearly show that the nuclear localization defective
mutant KK215,9AA leads to significantly reduced levels of
viral DNA in the nucleus, as compared to the wt and D64E
viruses (Fig. 5C and 5D). It suggests that the Q region is in
fact important for HIV-1 nuclear import. Consistently, a
recent study by Lu et al also observed that infection of
K215A/K219A mutant induced more than 3-fold lower
luc activity compared to class I IN mutant D64N/D116N
[16]. Moreover, similar to our experimental system, their
study revealed that, in the context of VSV-G pseudotyped
virus infection in Jurkat cells, 2-LTR circle DNA levels of
K215A/K219A and Q214L/Q216L were significantly
lower than other mutants V165A and C130G, even
though the inhibition of viral reverse transcription medi-
ated by these mutants were comparable [16]. In addition,
KK240,4AE mutant also showed a modest impairment of
viral DNA nuclear import (Fig. 5C and 5D). In fact, this
mutant exhibited the most profound infection defect,
compared to other two mutants (KK215,9AA and
RK263,4AA) (Fig. 3 and 4). This may be due to combined
effects of this mutant on both reverse transcription and
viral DNA nuclear import, as shown in Fig. 5. One inter-
esting question is whether such profound infection defect
of KK240,4AE mutant virus could be due to a structural
alteration by replacing glutamic acid (E) for lysine at posi-
tion of 244. It seems to be unlikely since 1) the effect of
this mutant on nuclear import was not as dramatic as
KK215,9AA mutant (as shown in Fig. 5); 2) Wiskerchen et
al have reported that infection of MAGI cells with two
other IN mutants K236A/K240A and K244A/E246A
mutants, that are located in the same region as our
KK240,4AE mutant, resulted in 0 and 4 β-Gal positive
cells, while infection of class I IN mutants produced 700
to 1400 β-Gal positive cells [15]. All of these observations
suggest that this region indeed plays an important role for
IN activities during early stage of virus infection prior to
integration. Also, it has to be noted that although similar
inhibition of reverse transcription was seen for
KK215,9AA and RK263,4AA mutants, RK263,4AA mutant
induced two to three fold higher level of β-Gal positive
cells and luc activity than KK215,9AA mutant (Fig. 3 and
4). This is expected since KK215,9AA affected both reverse
transcription and nuclear import, while RK263,4AA
mutant only impaired reverse transcription (Fig. 5). In
addition, our analysis could not detect viral DNA integra-
tion in each C-terminal mutant infection (Fig. 6), even
though they displayed various low levels of nucleus-asso-
ciated viral DNA (Fig. 5C). It suggests that these IN
mutants may also negatively affect viral integration during
their infection. Alternatively, it could be possible that
these mutants may have additional defect(s) at an unde-
fined postnuclear entry step that is required for viral DNA
integration, as suggested by Lu et al [16]. Consistently,
their recent reports have shown that several IN mutants in
same regions, including K215A/K219A, E244A and
R262A/K264A, completely lost virus replication ability in
CD4+ Jurkat T cells [16,42].
Up to now, the mechanism(s) underlying the action of
HIV-1 IN in viral PIC nuclear import is still unclear. Since
IN is a component of viral PIC, at least two factors may
affect the contribution of IN to viral PIC nuclear import:
first, IN needs to directly or indirectly associate with viral
DNA and/or other PIC-associated proteins in order to par-
ticipate in driving viral DNA into the nucleus; second, IN
needs to have a NLS and/or bind to other karyophilic pro-
teins for nuclear translocation. Any mutation disrupting
one of these two abilities would affect IN's action for viral
DNA nuclear import. A recent study evaluated the effect of
several IN core domain mutants targeting key residues for
DNA recognition on HIV-1 replication and indicated that,
while all of these IN mutants maintained their karyophilic
properties, viruses harboring these mutants still severely
impaired viral DNA nuclear import [4]. In our study, both
KK215,9AA and KK240,4AE mutants clearly lost their
karyophilic properties and negatively affected viral DNA
nuclear import. However, it is still premature to definePage 11 of 15
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described IN mutant Q214/216L, which is also located in
proximal tri-lysine domain, has been shown to reduce IN-
karyopherin α interaction in vitro [3]. More studies are
required for further characterization of molecular mecha-
nisms underlying the action of these IN mutants during
HIV-1 DNA nuclear import.
Conclusion
Taken together, the results presented here highlight that
all three C-terminal mutants tested in this study resulted
in drastic loss of viral infectivity that were due to defects
in different early steps of viral replication. Specific lysine
mutations introduced in the tri-lysine regions of the C-ter-
minal domain of HIV-1 IN, especially for KK215,9AA,
impaired protein nuclear accumulation and HIV-1 PIC
nuclear import. Although all of C-terminal mutants inhib-
ited viral reverse transcription to different extents,
KK240,4AE mutant exhibited most profound effect on
this step. These results suggest that the tri-lysine regions
(211KELQKQITK and 236KGPAKLLWK) in the C-terminal
of IN are important for HIV-1 reverse transcription and/or
nuclear import. More studies are underway to further
characterize the mechanisms involved in the action of
these regions during early steps of HIV-1 replication.
Materials and methods
Construction of different IN expressors and HIV-1 RT/IN 
defective provirus
The full-length wild-type HIV-1 IN cDNA was amplified
by polymerase chain reaction (PCR) using HIV-1 HxBru
strain [30] as template and an engineered initiation codon
(ATG) was placed prior to the first amino acid (aa) of IN.
The primers are 5'-IN-HindIII-ATG (5'-GCGCAAGCTT-
GGATAGATGTTTTTAGATGGAA-3') and 3'-IN-Asp718
(5'-CCATGTGTGGTACCTCATCCTGCT-3'). The PCR
product was digested with HindIII and Asp718 restriction
enzymes and cloned in frame to 5' end of EYFP cDNA in
a pEYFP-N1 vector (BD Biosciences Clontech) and gener-
ated a IN-YFP fusion expressor. Also, cDNA encoding for
truncated IN (aa 50 to 288 or aa 1 to 212) was amplified
by PCR and also cloned into pEYFP-N1 vector. The prim-
ers for generation of IN50-288 cDNA are IN50-HindIII-
ATG-5'(5'– GCGCAAGCTTGGATAGATGCATGGACAAG-
TAG-3) and 3'-IN-Asp718 and primers for amplifying
IN1-212 cDNA are IN-HindIII-ATG-5' and IN-212-XmaI-
3'(5'-CAATTCCCGGGTTTGTATGTCTGTTTGC-3). IN
substitution mutants INKK215,9AA-YFP, INKK240,4AE-YFP and
INRK263,4AA-YFP, were generated by a two-step PCR-based
method [43] by using a 5'-primer (5'-IN-HindIII-ATG), a
3'-primer (3'-IN-Asp718) and complementary primers
containing desired mutations. Amplified IN cDNAs har-
boring specific mutations were then cloned into pEYFP-
N1 vector. To improve the expression of each IN-YFP
fusion protein, all IN-YFP fusing cDNAs were finally sub-
cloned into a SVCMV vector, which contains a cytomega-
lovirus (CMV) immediate early gene promoter [43].
To construct HIV-1 RT/IN defective provirus NLluc∆B-
gl∆RI, we used a previously described HIV-1 envelope-
deleted NLluc∆BglD64E provirus as the backbone (kindly
provided by Dr. Irvin S.Y. Chen). In this provirus, the nef
gene was replaced by a firefly luciferase gene [33]. The
ApaI/SalI cDNA fragment in NLlucBglD64E was replaced
by the corresponding fragment derived from a HIV-1 RT/
IN deleted provirus R-/∆RI [32] and generated a RT/IN
deleted provirus NLluc∆Bgl∆RI, in which RT and IN gene
sequences were deleted while a 194-bp sequence harbor-
ing cPPT/CTS cis-acting elements was maintained. To
restore HIV-1 envelope gene sequence in NLluc∆Bgl∆RI
provirus, the SalI/BamHI cDNA fragment in this provirus
was replaced by a corresponding cDNA fragment from a
HIV-1 envelope competent provirus R-/∆RI [32] and the
resulting provirus is named as NLluc∆RI. To functionally
complement RT/IN defects of NLluc∆Bgl∆RI, a CMV-Vpr-
RT-IN fusion protein expressor [32] was used in this
study. Co-transfection of NLluc∆Bgl∆RI, CMV-Vpr-RT-IN
and a vesicular stomatitis virus G (VSV-G) glycoprotein
expressor results in the production of VSV-G pseudotyped
HIV-1 that can undergo for single cycle replication in dif-
ferent cell types [32]. To investigate the effect of IN
mutants on viral replication, different mutants
KK215,9AA, KK240.4AE, RK263,4AA or D64E were intro-
duced into CMV-Vpr-RT-IN expressor by PCR-based
method as described above and using a 5'-primer corre-
sponding to a sequence in RT gene and including a natural
NheI site (5'-GCAGCTAGCAGGGAGACTAA-3'), a 3'-
primer (3'-IN-stop-PstI, 5'– CTGTTCCTGCAGCTAATCCT-
CATCCTG-3') and the complementary oligonucleotide
primers containing desired mutations. All IN mutants
were subsequently analyzed by DNA sequencing to con-
firm the presence of mutations or deletions.
Cell lines and reagents
Human embryonic kidney 293T, HeLa and HeLa-CD4-
CCR5-β-Gal cells were maintained in Dulbecco's Modi-
fied Eagles Medium (DMEM) supplemented with 10%
fetal calf serum (FCS). Human C8166 T-lymphoid cells
were maintained in RPMI-1640 medium. Antibodies used
in the immunofluorescent assay, immunoprecipitation or
western blot are as follows: The HIV-1 positive human
serum 162 and anti-HIVp24 monoclonal antibody used
in this study were previously described [44]. The rabbit
anti-GFP and anti-IN antibodies were respectively
obtained from Molecular Probes Inc and through AIDS
Research Reference Reagent Program, Division of AIDS,
NIAID, NIH. Aphidicolin was obtained from Sigma Inc.Page 12 of 15
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DNA transfection in 293T and HeLa cells were performed
with standard calcium phosphate DNA precipitation
method. For immunofluorescence analysis, HeLa cells
were grown on glass coverslip (12 mm2) in 24-well plate.
After 48 h of transfection, cells on the coverslip were fixed
with PBS-4% paraformaldehyde for 5 minutes, permeabi-
lized in PBS-0.2% Triton X-100 for 5 minutes and incu-
bated with primary antibodies specific for GFP or HIV-1
IN followed by corresponding secondary FITC-conjugated
antibodies. Then, cells on the coverslip were viewed using
a computerized Axiovert 200 inverted fluorescence micro-
scopy (Becton Deckson Inc).
Virus production and infection
Production of different single-cycle replicating virus
stocks and measurement of virus titer were previously
described [32]. Briefly, 293T cells were co-transfected with
RT/IN defective NLluc∆Bgl∆RI provius, a VSV-G expressor
and each of CMV-Vpr-RT-IN (wt/mutant) expressor. To
produce HIV-1 envelope competent single cycle
replicating virus, 293T cells were co-transfected with
NLluc∆RI and different CMV-Vpr-RT-IN (wt/mutant)
expressors. After 48 hours of transfection, supernatants
were collected and virus titers were quantified by RT activ-
ity assay [43].
To test the effect of IN mutants on virus infection, equal
amounts of virus were used to infect HeLa-CCR5-CD4-β-
Gal cells, dividing and non-dividing C8166 T cells. To
compare the infection of each viral stock in HeLa-CCR5-
CD4-β-Gal cells, numbers of infected cells (β-Gal positive
cells) were evaluated by the MAGI assay 48 hours post-
infection (p.i) as described previously [34]. To infect
CD4+ T cells, dividing or aphidicolin-treated non-divid-
ing C8166 T cells (with 1.3 µg/ml of aphidicolin) were
infected with equivalent amounts of single cycle replicat-
ing viruses (5 cpm/cell) for 2 hours. Then, infected cells
were washed and cultured in the absence or presence of
the same concentration of aphidicolin. At 48 hours post-
infection, 1 × 106 cells from each sample were collected,
washed twice with PBS, lysed with 50 µl of luciferase lysis
buffer (Fisher Scientific Inc) and then, 10 µl of cell lysate
was subjected to the luciferase assay by using a Top-
Count®NXT™ Microplate Scintillation & Luminescence
Counter (Packard, Meriden) and the luciferase activity
was valued as relative luciferase units (RLU). Each sample
was analyzed in duplicate and the average deviation was
calculated.
Immunoprecipitation and Western blot analyses
For detection of IN-YFP fusion proteins, 293T cells trans-
fected with each IN-YFP expressor were lysed with RIPA
lysis buffer and immunoprecipitated using human anti-
HIV serum. Then, immunoprecipitates were run in 12%
SDS-PAGE and analyzed by Western blot using rabbit
anti-GFP antibody. To analyze virion-incorporation of IN
and virus composition, 293T cells were co-transfected
with NLluc∆Bgl∆RI provirus and each of CMV-Vpr-RT-IN
(wt/mutant) expressors. After 48 hours, viruses were col-
lected, lysed with RIPA lysis buffer and immunoprecipi-
tated with human anti-HIV serum. Then,
immunoprecipitates were run in 12% SDS-PAGE and ana-
lyzed by Western blot with rabbit anti-IN antibody and
anti-p24 monoclonal antibody or anti-HIV serum.
HIV-1 reverse-transcribed and integrated DNA detection 
by PCR and Southern blotting
C8166 T cells were infected with equal amount of the wt
or IN mutant viruses for 2 hours, washed for three times
and cultured in RPMI medium. To detect total viral DNA
synthesis, at 12 hours post-infection, equal number (1 ×
106 cells) of cells were collected, washed twice with PCR
washing buffer (20 mM Tris-HCl, pH8.0, 100 mM KCl),
and lysed in lysis buffer (PCR washing buffer containing
0.05% NP-40, 0.05% Tween-20). Lysates were then incu-
bated at 56°C for 30 min with proteinase K (100 µg/ml)
and at 90°C for 10 min prior to phenol-chloroform DNA
purification. To detect viral cDNA from each sample, all
lysates were serially diluted 5-fold and subjected to PCR
analysis. The primers used to detect late reverse transcrip-
tion products were as following: 5'-LTR-U3, 5'-GGAT-
GGTGCTTCAAGCTAGTACC-3' (nt position 8807, +1 =
start of BRU of transcription initiation); 3'-Gag 5'-ACT-
GACGCTCTCGCACCCATCTCTCTC-3' (nt position 329).
The probe for southern blot detection was generated by
PCR with a 5'-LTR-U5 oligonucleotide, 5'-CTCTAGCAGT-
GGCGCCCGAACAGGGAC-3' (nt position 173) and the
3'-Gag oligo. PCR was carried out using 1× HotStar Taq
Master Mix kit (QIAGEN, Mississauga, Ontario), as
described previously [32].
To analyze nucleus- and cytoplasm-associated viral DNA,
a subcellular fractionation of infected C8166 T cells (2 ×
106) was performed after 24 hours of infection, as
described previously [37]. Briefly, infected cells were pel-
leted and resuspended in ice-cold PCR lysis buffer (wash-
ing buffer containing 0,1% NP-40). After a 5-min
incubation on ice, the nucleus was pelleted by centrifuga-
tion, washed twice with PCR wash buffer, and lysed in
lysis buffer (0,05% NP-40, 0,05% Tween-20). Then, both
cytoplasmic sample (supernatant from the first centrifuga-
tion) and the nuclear sample were treated with proteinase
K and used for PCR analysis, as described above.
Integrated proviral DNA was detected in cell lysates by a
modified nested Alu-PCR [32], in which following the
first PCR, a second PCR was carried-out to amplify a por-
tion of the HIV-1 LTR sequence from the first Alu-LTR
PCR-amplified products. The first PCR was carried out byPage 13 of 15
(page number not for citation purposes)
Retrovirology 2005, 2:62 http://www.retrovirology.com/content/2/1/62using primers including 5'-Alu oligo (5'-
TCCCAGCTACTCGGGAGGCTGAGG-3') and 3'-LTR
oligo (5'-AGGCAAGCTTTATTGAGGGCTTAAGC-3') (nt
position 9194) located respectively in the conserved
region of human Alu sequence and in HIV-1 LTR. The
primer used for both of the second nested PCR and for
generating a probe are 5'-NI: 5'-CACACACAAGGCTACT-
TCCCT-3' and 3'-NI: 5'-GCCACTCCCCAGTCCCGCCC-
3'. As a control, the first and second PCR primer pairs were
also used in parallel to detect integrated viral DNA from
serially diluted ACH-2 cells, which contain one viral copy/
cell, in a background of uninfected C8166 cellular DNA.
To evaluate the DNA content of extracted chromosomal
DNA preparations, detection of human β-globin gene was
carried-out by PCR, as described previously [37]. All final
PCR products were electrophoresed through 1.2% agarose
gel and transferred to hybridization transfer membrane
(GeneScreen Plus, PerkinElmer Life Sciences), subjected
to Southern hybridization by using specific PCR DIG-
Labeling probes (Roche Diagnostics, Laval, Que) and
visualized by a chemiluminescent method. Densitometric
analysis was performed using a Personal Molecular
Imager (Bio-Rad) and Quantity One software version 4.1.
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